Session 3: Hot Topics 1

New Devices and Emerging Therapies

Moderators: Gerhard Scheuch (Activaero, Gemunden, Germany) and Rajiv Dhand (University of Tennessee)

Performance Testing of a Novel Continuous Powder Aerosolizer (CPA) for Inhalative Administration of Surfactant to Preterm Neonates

O Helwich1, W Koch1, P Iwatschenko2, H Windt1, FJH Taut3, C De Muynck4, and G Pohlmann1

1Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany
2MTF MediTech Franken GmbH, Eckental, Germany
3Takeda Pharmaceuticals Int’l, Zürich, Switzerland
4Nycomed: a Takeda Company, Konstanz, Germany

Feasibility Testing of Low Molecular Weight Heparin (LMWH): Loaded Large Porous PEG-PLGA Microparticles for the Treatment of Asthma

B Patel, N Gupta and F Ahsan

Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX, United States of America

Bioengineering of siRNA for Treatment of Inflammatory Lung Disease

JM Ramsey1, C Kelly2, AB Yadav1, NG McElvaney4, D Small3, C Taggart3, and SA Cryan1

1 School of Pharmacy, Royal College of Surgeons in Ireland, Dublin 2, Ireland
2
School of Biology and Environment Science, University College Dublin, Dublin 4, Ireland
3
Centre for Infection and Immunity, Queen’s University Belfast, Belfast, United Kingdom
4
Respiratory Research Division, RCSI, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland

Efficacy of Inhaled Liposome-Encapsulated Ciprofloxacin against Yersinia Pestis

KA Hamblin1, JD Blanchard2, C Davies1, SV Harding1, and AJH Simpson1

1 Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire, United Kingdom
2
Aradigm Corporation, Hayward, CA, United States of America